Spatially confined photoacoustic effects of responsive nanoassembly boosts lysosomal membrane permeabilization and immunotherapy of triple-negative breast cancer

被引:0
|
作者
Li, Kunlin [1 ]
Li, Lin [1 ]
Xie, Xiyue [1 ]
Zhu, Jing [1 ]
Xia, Daqing [1 ]
Xiang, Lunli [1 ]
Cai, Kaiyong [1 ]
Zhang, Jixi [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, 174 Shazheng St, Chongqing 400044, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor immunotherapy; Responsive self-assembly; Photoacoustic effects; Lysosomal membrane permeabilization; Endoplasmic reticulum stress; THERAPY;
D O I
10.1016/j.actbio.2024.08.021
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Although immunogenic cell death (ICD) induced by lysosomal membrane permeabilization (LMP) evidently enhance the effectiveness of antitumor immunity for triple-negative breast cancer (TNBC) with poor immunogenicity, their potential is increasingly restricted by the development of other death pathways and the repair of lysosomes by endoplasmic reticulum (ER) during LMP induction. Herein, a poly- dopamine nanocomposite with i-motif DNA modified and BNN6 loaded is prepared toward boosting LMP and immunotherapy of TNBC by synergy of spatially confined photoacoustic (PA) effects and nitric oxide. Combining the high-frequency pulsed laser (40 0 0 kHz) with the intra-lysosomal assembly of nanocomposites produced spatially confined and significantly boosted PA effects (4.8-fold higher than the individually dispersed particles extracellular), suppressing damage to other cellular components and selectively reducing lysosomal integrity to 19.2 %. Simultaneously, the releasing of nitric oxide inhibited the repair of lysosomes by ER stress, causing exacerbated LMP. Consequently, efficient immune activation was achieved, including the abundant releasing of CRT/HMGB1 (5.93-6.8-fold), the increasing maturation of dendritic cells (3.41-fold), and the fostered recruitment of CD4+/CD8+ T cells (3.99-3.78-fold) in vivo . The study paves a new avenue for the rational design and synergy of confined energy conversion and responsive nanostructures to achieve the treatment of low immunogenicity tumors.
引用
收藏
页码:381 / 395
页数:15
相关论文
共 50 条
  • [41] 'IMpassionate conflicts' in immunotherapy trials for metastatic triple-negative breast cancer
    Voorwerk, L.
    Kok, M.
    ANNALS OF ONCOLOGY, 2021, 32 (08) : 947 - 949
  • [42] Role of Immunotherapy in the Treatment of Triple-Negative Breast Cancer: A Literature Review
    Patel, Khushbu K.
    Hassan, Danial
    Nair, Shaalina
    Tejovath, Sreedevi
    Kahlon, Simranjit S.
    Peddemul, Aishwarya
    Sikandar, Rabia
    Mostafa, Jihan A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [43] Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?
    Palleschi, Michela
    Maltoni, Roberta
    Sarti, Samanta
    Melegari, Elisabetta
    Bravaccini, Sara
    Rocca, Andrea
    BREAST JOURNAL, 2020, 26 (04): : 739 - 742
  • [44] Trends and Disparities in the Use of Immunotherapy for Triple-Negative Breast Cancer in the US
    Freeman, Jincong Q.
    Huo, Dezheng
    Shubeck, Sarah P.
    Chen, Nan
    Yarlagadda, Sudha R.
    Nanda, Rita
    Howard, Frederick M.
    JAMA NETWORK OPEN, 2025, 8 (02)
  • [45] Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome
    Li, Liying
    Zhang, Fan
    Liu, Zhenyu
    Fan, Zhimin
    CANCERS, 2023, 15 (01)
  • [46] Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer
    Aleckovic, Masa
    Li, Zheqi
    Zhou, Ningxuan
    Qiu, Xintao
    Lulseged, Bethlehem
    Foidart, Pierre
    Huang, Xiao-Yun
    Garza, Kodie
    Shu, Shaokun
    Kesten, Nikolas
    Li, Rong
    Lim, Klothilda
    Garrido-Castro, Ana C.
    Guerriero, Jennifer L.
    Qi, Jun
    Long, Henry W.
    Polyak, Kornelia
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (11) : 1304 - 1318
  • [47] Advancing immunotherapy for early-stage triple-negative breast cancer
    Di Cosimo, Serena
    LANCET, 2020, 396 (10257): : 1046 - 1048
  • [48] Immunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects
    Ahmed, Rida Fatima
    Jameel, Farwah
    Irfan, Muhammad
    CRITICAL REVIEWS IN IMMUNOLOGY, 2019, 39 (03) : 211 - 221
  • [49] Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
    Kudelova, Eva
    Smolar, Marek
    Holubekova, Veronika
    Hornakova, Andrea
    Dvorska, Dana
    Lucansky, Vincent
    Koklesova, Lenka
    Kudela, Erik
    Kubatka, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [50] Immunotherapy in triple-negative breast cancer: A literature review and new advances
    Valencia, Guillermo Arturo
    Rioja, Patricia
    Morante, Zaida
    Ruiz, Rossana
    Fuentes, Hugo
    Castaneda, Carlos A.
    Vidaurre, Tatiana
    Neciosup, Silvia
    Gomez, Henry L.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (03): : 219 - 236